Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ICU Medical, Inc. - Common Stock (NQ:ICUI)

160.34 +3.16 (+2.01%)
Delayed Quote Updated: 2:50 PM EDT, Oct 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about ICU Medical, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
News headline image
2 Volatile Stocks to Target This Week and 1 We Turn Down
Market swings can be tough to stomach, and volatile stocks often experience exaggerated moves in both directions. While many thrive during risk-on environmen... 
Via StockStory
Topics Energy
News headline image
ICU Medical CFO Sells 6,381 Shares for $1.1 Million ↗
The sale was part of a trading plan established in June. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
ICU Medical CFO Brian Bonnell Sells 9,307 Shares ↗
Bonnell retains 62,443 direct shares. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Q2 Earnings Highlights: ICU Medical (NASDAQ:ICUI) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks
Let’s dig into the relative performance of ICU Medical (NASDAQ:ICUI) and its peers as we unravel the now-completed Q2 medical devices & supplies - cardiology... 
Via StockStory
ICU Medical (NASDAQ:ICUI) Q2 Earnings Beat, FY2026 Guidance Raised ↗
Via Chartmill
Topics Earnings
ICU Medical Inc (NASDAQ:ICUI) Beats Q1 2026 Earnings Estimates as Core Segments Show Growth ↗
Via Chartmill
News headline image
1 Small-Cap Stock with Promising Prospects and 2 We Brush Off
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that ... 
Via StockStory
News headline image
ICU Medical (ICUI): Buy, Sell, or Hold Post Q2 Earnings?
ICU Medical has had an impressive run over the past six months as its shares have beaten the S&P 500 by 9.3%. The stock now trades at $182.79, marking a 23.3... 
Via StockStory
Topics Stocks
News headline image
ICU Medical (ICUI) Q2 2026 Earnings Call Transcript ↗
Infusion Systems revenue hit record highs with 12% organic growth and strong pump sales. 
Via The Motley Fool
Topics Earnings World Trade
News headline image
The 5 Most Interesting Analyst Questions From ICU Medical’s Q2 Earnings Call
ICU Medical’s second quarter results were well received by the market, with management highlighting robust performance in the Infusion Systems and Consumable... 
Via StockStory
Topics Earnings World Trade
News headline image
2 Russell 2000 Stocks to Target This Week and 1 That Underwhelm
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However,... 
Via StockStory
News headline image
ICUI Q2 Deep Dive: Margin Expansion and Infusion Systems Drive Outperformance
Medical device company ICU Medical (NASDAQ:ICUI) reported Q2 CY2026 results beating Wall Street’s revenue expectations, but sales were flat year on year at $... 
Via StockStory
Topics World Trade
News headline image
ICU Medical (ICUI) Shares Skyrocket, What You Need To Know
What Happened? Shares of medical device company ICU Medical (NASDAQ:ICUI) jumped 10.2% in the afternoon session after the company posted strong second-quarte... 
Via StockStory
Topics Earnings
News headline image
ICU Medical Analysts Boost Their Forecasts Following Upbeat Q2 Earnings ↗
ICU Medical Inc (NASDAQ:ICUI) reported strong Q2 earnings of $2.37 per share and raised its FY2026 guidance. Analysts have increased price targets for the stock. 
Via Benzinga
News headline image
ICU Medical Q2 Earnings Call Highlights ↗
ICU Medical (NASDAQ:ICUI) reported second-quarter revenue of $548 million, up 6% organically and 1% on a reported basis, as growth in its consumables and infusion systems businesses helped offset... 
Via MarketBeat
Topics Earnings
News headline image
ICU Medical (NASDAQ:ICUI) Reports Strong Q2 CY2026
Medical device company ICU Medical (NASDAQ:ICUI) reported Q2 CY2026 results beating Wall Street’s revenue expectations, with sales up 1.5% year on year to $5... 
Via StockStory
News headline image
ICU Medical (ICUI) Reports Q2: Everything You Need To Know Ahead Of Earnings
Medical device company ICU Medical (NASDAQ:ICUI) will be reporting earnings this Thursday after market close. Here’s what you need to know. ICU Medical beat ... 
Via StockStory
Topics Artificial Intelligence
News headline image
1 Unpopular Stock That Deserves Some Love and 2 We Brush Off
Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cord... 
Via StockStory
News headline image
2 Momentum Stocks on Our Watchlist and 1 We Ignore
The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorab... 
Via StockStory
News headline image
2 Healthcare Stocks for Long-Term Investors and 1 We Brush Off
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the charge have not only reali... 
Via StockStory
News headline image
ICU Medical (ICUI): Buy, Sell, or Hold Post Q1 Earnings?
ICU Medical has been treading water for the past six months, recording a small loss of 3.3% while holding steady at $142.98. The stock also fell short of the... 
Via StockStory
Topics Economy
News headline image
Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a... 
Via StockStory
News headline image
1 Cash-Producing Stock with Impressive Fundamentals and 2 We Avoid
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient... 
Via StockStory
News headline image
ICU Medical's General Counsel Sells — The Smiths Integration Is Almost Done, the Proof Isn'tICU Medical's General Counsel Sells — The Smiths Integration Is still playing out. ↗
This infusion therapy specialist reported a notable insider sale as shares continue to lag over the past year. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
2 Small-Cap Stocks with Solid Fundamentals and 1 Facing Headwinds
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in th... 
Via StockStory
News headline image
5 Must-Read Analyst Questions From ICU Medical’s Q1 Earnings Call
ICU Medical’s first quarter results in 2026 were marked by outperformance against Wall Street expectations, with revenue and non-GAAP earnings per share both... 
Via StockStory
Topics Earnings
News headline image
2 Profitable Stocks with Exciting Potential and 1 We Turn Down
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does... 
Via StockStory
News headline image
ICU Medical (ICUI) Q1 2026 Earnings Transcript ↗
ICU Medical (ICUI) Q1 2026 Earnings Transcript 
Via The Motley Fool
Topics World Trade
News headline image
ICUI Q1 Deep Dive: Infusion Systems and Consumables Offset Vital Care Weakness
Medical device company ICU Medical (NASDAQ:ICUI) reported Q1 CY2026 results exceeding the market’s revenue expectations, but sales fell by 12.3% year on year... 
Via StockStory
Topics World Trade
News headline image
ICU Medical (NASDAQ:ICUI) Exceeds Q1 CY2026 Expectations
Medical device company ICU Medical (NASDAQ:ICUI) beat Wall Street’s revenue expectations in Q1 CY2026, but sales fell by 11.6% year on year to $530.2 million... 
Via StockStory
Topics Artificial Intelligence
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.